GlassScriptPhysician profile
Gerald W Thorpe
NPI 1720027923
$1,284.10
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $559 · 2020: $60.14 · 2021: $628 · 2022: $37.13.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $610.23 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $120.81 | 2019 | |
| Abbvie INC. | $112.86 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $89.09 | 2019-2020 | |
| Amgen INC. | $74.09 | 2019 | |
| Novo Nordisk INC | $44.75 | 2019 | |
| Lilly USA, LLC | $39.52 | 2019 | |
| Grt US Holding, INC. | $39.44 | 2021-2022 | |
| Amarin Pharma, INC. | $34.95 | 2019 | |
| Arbor Pharmaceuticals, INC. | $27.86 | 2019 | |
| Roche Diagnostics Corporation | $19.96 | 2019 | |
| Sanofi Pasteur INC. | $19.47 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $15.37 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $13.35 | 2019 | |
| Kowa Pharmaceuticals America, INC. | $11.77 | 2019 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Daiichi Sankyo INC. | $10.58 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gerald Thorpe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.